CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 32,520 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 6,500 shares at $1.16 ($7,540)
- 4 Planned sale Chief Medical Officer sold 13,654 shares at $0.88 ($12,044)
- 4 Planned sale President and CEO sold 56,000 shares at $0.89 ($49,610)
- 4 Planned sale Chief Financial Officer sold 40,000 shares at $0.89 ($35,492)
- 4 Open-market buy Director bought 10,000 shares at $0.82 ($8,164)
- 4 Open-market buy Director bought 13,469 shares at $0.82 ($11,045)
- 4 Open-market buy Director bought 10,000 shares at $0.81 ($8,134)
- 4 Open-market buy Director bought 500 shares at $2.60 ($1,300)
Page 4 of 39 · 776 filings